ÑéÖ¤ÐÔʵÑé,verified experimentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÁ¹ý¸ººÉ,Aluminum overloadÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Åàѵ·½°¸,training schemeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °¸ÀýÑ¡Ôñ,case selectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·çÏÕ¹ÜÀí´ëÊ©,risk management measureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹«¿ªÍ¸Ã÷,Open and TransparentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿â´æÖÜתÂÊ,inventory turnoverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î°ÐÏò¸øÒ©ÏµÍ³,Lung Targeting Drug Delivery SystemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶³¸ÉÈé,Lyophilized emulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÒ±¶ËûÃ×ËÉÁ×ËáįעÉäÒº,Dexbetamethasone Sodium Phosphate InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HIV-1ÕûºÏøÒÖÖÆ¼Á,HIV-1 integrase inhibitorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈýµªßòÑÜÉúÎï,triazole derivativesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½µÑªÑ¹»îÐÔ,antihypertensive activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³õ²½Ò©Ð§Ñ§,preliminary pharmacodynamicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÇ¿Á¦Ã¹ËØ,Doxycycline hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏõËáïØ,gallium nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏõËá²¼¿µßò,Butoconazole nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¨Î¬µØÂ寬,Carvedilol TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉúÎï𤸽΢Çò,bioadhesive microspheresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ƥ·ôͶҩ,cutaneous administrationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« º¬Á¿¿ØÖÆ,content controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÜÕÍËÙÂÊ,hydrated rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µâÀë×ÓÑ¡Ôñµç¼«,Iodide ion-selective electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ̼ÄÉÃ×¹ÜÐÞÊε缫,carbon nanotubes modified glassy carbon electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èýάԭ×Ó³¡È«Ï¢×÷ÓÃʸÁ¿(3D-HoVAIF),three-dimensional holographic vector of atomic interaction field(3D-HoVAIF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑôÀë×ÓÊ÷Ö¬,cation resinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈܼÁ²ÐÁô,Residual SolventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±½ÒÒͪËá,Phenylglyoxylic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼·³ö¹öÔ²·¨,extrusion-spheronizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« îéĤµç¼«,bismuth-film electrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ÙÄý¼Á,coagulantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖØ¾ù·Ö×ÓÁ¿,weight average molecular weightÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÆÕĪ¿¨Òò,pramoxine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ÔôÇ»ù±½ÒÒ´¼,p-hydroxyphenylethyl alcoholÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹ÒÖÓô»îÐÔ,antidepressant activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈܼÁ²ÐÁôÁ¿,solvent residueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆÀ¼ÛÄÚÈÝ,Evaluation contentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ABC·ÖÎö·¨,ABC analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« º¬Áò°±»ùËá,sulfur-containing amino acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àôÇ»ùçÞ´¼,polyhydroxy sterolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Áò»¯ïÓÁ¿×Óµã,CdS quantum dotsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Áã¿â´æ¹ÜÀí,zero inventory managementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Æ·ÖÊÁ¿,Drug qualityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« öÑÓã,spanish mackerelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À©É¢³Ø,Diffusion chamberÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢ÈéÒºÏàÉ«Æ×,Microemulsion liquid chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹û½º¸Æ,calcium pectinateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇàÃ¹ËØV¼ØÆ¬,Phenoxymethylpenicillin Potassium TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Òõ¡¢ÑôÀë×Ó,anions and cationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Îȶ¨ÐÔ¿¼²ì,stability testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉúÎï𤸽Ƭ,bioadhesive tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ãð¾ú×¢ÉäÓÃË®,sterile water for injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇÅç¼Á,nasal sprayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò½ÓÃÑõ,medical oxygenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞË®ÑÇÁòËáÄÆ,anhydrous sodium sulfiteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅçÎí¸ÉÔïÈé¼Á,spray-dried emulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¾ú¹¤ÒÕ,aseptic processingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËá°ëë×°±Ëá,Cysteine HydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢·ÖµçλÈܳö,differential potentiometric stripping analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´ÏàÐü¸¡·¨,inverse suspension methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Ï¶ú½º,guar gumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« MgCl2,magnesium chlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÊÁ¿¿¼²ì,quality investigationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒºÌå¶¥¿ÕÆøÏàÉ«Æ×·¨,Solution headspace gas chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ƕ¶Î¹²¾ÛÎï½ºÊø,block copolymer micellesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÒ´¼ÈܼÁ²ÐÁô,residual ethanol solventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÚÇ»À£ÑñĤ,oral ulcer filmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ôDZû»ù¼×»ùÏËÎ¬ËØÁÚ±½¶þ¼×Ëáõ¥,hydroxypropyl methylcellulose phthalateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËá¶þÇâ°£ÍзÈ,Dihydroetorphine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒõÀë×Ó½»»»²ãÎö,Anion exchange chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CoreyÄÚõ¥,Corey lactoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È黯-ÈܼÁ»Ó·¢·¨,emulsion-solvent evaporation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦ÈܽºÄÒ,Enteric-coated capsulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó㾫µ°°×Äý¾Û·¨,protamine aggregation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ü½á²ð·Ö,inclusion resolutionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖØÁ¿²îÒì,weight variationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ùÖÊÅä·½,media formulaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸»ÂíËá¸£ÄªÌØÂÞ,formoterol fumarateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬ÉùÓÕµ¼,ultrasonic inductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²¹¤×÷,clinical workÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×÷ÓÃÌØµã,action charactersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« É«¸ÊËáÄÆ,sodium cromoglycateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×î¼Ñ×éºÏ,best combinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÁ·¥Ëû͡Ƭ,Simvastatin TabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÀ×ŵàº,Ranolazine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¨Ã¸¢ñ,nicotinamide adenine dinucleotideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖлªÑÛ¾µÉßÉß¶¾,Chinese Cobra venomÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶³¸É¼¼Êõ,freeze-drying technologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂíÀ´Ëáäå±½ÄÇÃô,brompheniramine maleateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸´·½ÌæÏõßòº¬ÊþÒº,Compound Tinidazole GarglesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áºÏ²ÎÊý,binding parametersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Æ·Ñз¢,Drug Research and DevelopmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« PPAR¼¤¶¯¼Á,PPAR agonistÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« άCÒøÇÌÆ¬,vitamin C Yinqiao tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄáÃÀÊæÀûƬ,Nimesulide tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáŵ·úɳÐÇ,norfloxacin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×¢ÉäÓû¹Ô­Ð͹Èë׸ÊëÄ,Reduced Glutathione for InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« H/D½»»»,H/D exchangeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« D-°±»ùÆÏÌÇÑÎËáÑÎ,D-glucosamine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« éÙÇàù,Penicillium citrinumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«